164 related articles for article (PubMed ID: 31797602)
21. Mutational signatures are markers of drug sensitivity of cancer cells.
Levatić J; Salvadores M; Fuster-Tormo F; Supek F
Nat Commun; 2022 May; 13(1):2926. PubMed ID: 35614096
[TBL] [Abstract][Full Text] [Related]
22. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution.
Rosenthal R; McGranahan N; Herrero J; Taylor BS; Swanton C
Genome Biol; 2016 Feb; 17():31. PubMed ID: 26899170
[TBL] [Abstract][Full Text] [Related]
23. The clock-like accumulation of germline and somatic mutations can arise from the interplay of DNA damage and repair.
Spisak N; de Manuel M; Milligan W; Sella G; Przeworski M
PLoS Biol; 2024 Jun; 22(6):e3002678. PubMed ID: 38885262
[TBL] [Abstract][Full Text] [Related]
24. Patterns and processes of somatic mutations in nine major cancers.
Jia P; Pao W; Zhao Z
BMC Med Genomics; 2014 Feb; 7():11. PubMed ID: 24552141
[TBL] [Abstract][Full Text] [Related]
25. Unraveling the genomic landscape of colorectal cancer through mutational signatures.
Díaz-Gay M; Alexandrov LB
Adv Cancer Res; 2021; 151():385-424. PubMed ID: 34148618
[TBL] [Abstract][Full Text] [Related]
26. Mutational spectra are associated with bacterial niche.
Ruis C; Weimann A; Tonkin-Hill G; Pandurangan AP; Matuszewska M; Murray GGR; Lévesque RC; Blundell TL; Floto RA; Parkhill J
Nat Commun; 2023 Nov; 14(1):7091. PubMed ID: 37925514
[TBL] [Abstract][Full Text] [Related]
27. Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy.
Hatakeyama K; Nagashima T; Ohshima K; Ohnami S; Ohnami S; Shimoda Y; Serizawa M; Maruyama K; Naruoka A; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K
Cancer Sci; 2019 Aug; 110(8):2620-2628. PubMed ID: 31152682
[TBL] [Abstract][Full Text] [Related]
28. Accuracy of mutational signature software on correlated signatures.
Wu Y; Chua EHZ; Ng AWT; Boot A; Rozen SG
Sci Rep; 2022 Jan; 12(1):390. PubMed ID: 35013428
[TBL] [Abstract][Full Text] [Related]
29. Modeling clinical and molecular covariates of mutational process activity in cancer.
Robinson W; Sharan R; Leiserson MDM
Bioinformatics; 2019 Jul; 35(14):i492-i500. PubMed ID: 31510643
[TBL] [Abstract][Full Text] [Related]
30. Divergence of mutational signatures in association with breast cancer subtype.
Perry G; Dadiani M; Kahana-Edwin S; Pavlovski A; Markus B; Hornung G; Balint-Lahat N; Yosepovich A; Hout-Siloni G; Jacob-Hirsch J; Sklair-Levy M; Friedman E; Barshack I; Kaufman B; Gal-Yam EN; Paluch-Shimon S
Mol Carcinog; 2022 Nov; 61(11):1056-1070. PubMed ID: 36111610
[TBL] [Abstract][Full Text] [Related]
31. A Compendium of Mutational Signatures of Environmental Agents.
Kucab JE; Zou X; Morganella S; Joel M; Nanda AS; Nagy E; Gomez C; Degasperi A; Harris R; Jackson SP; Arlt VM; Phillips DH; Nik-Zainal S
Cell; 2019 May; 177(4):821-836.e16. PubMed ID: 30982602
[TBL] [Abstract][Full Text] [Related]
32. Correlation-based and feature-driven mutation signature analyses to identify genetic features associated with DNA mutagenic processes in cancer genomes.
Jeong HY; Yoo J; Kim H; Kim TM
Genomics Inform; 2021 Dec; 19(4):e40. PubMed ID: 35172473
[TBL] [Abstract][Full Text] [Related]
33. Influence network model uncovers relations between biological processes and mutational signatures.
Amgalan B; Wojtowicz D; Kim YA; Przytycka TM
Genome Med; 2023 Mar; 15(1):15. PubMed ID: 36879282
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms underlying mutational signatures in human cancers.
Helleday T; Eshtad S; Nik-Zainal S
Nat Rev Genet; 2014 Sep; 15(9):585-98. PubMed ID: 24981601
[TBL] [Abstract][Full Text] [Related]
35. MutationalPatterns: the one stop shop for the analysis of mutational processes.
Manders F; Brandsma AM; de Kanter J; Verheul M; Oka R; van Roosmalen MJ; van der Roest B; van Hoeck A; Cuppen E; van Boxtel R
BMC Genomics; 2022 Feb; 23(1):134. PubMed ID: 35168570
[TBL] [Abstract][Full Text] [Related]
36. Mutation Signatures Depend on Epigenomic Contexts.
Coleman N; De S
Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349
[TBL] [Abstract][Full Text] [Related]
37. Analysis of mutational signatures with yet another package for signature analysis.
Hübschmann D; Jopp-Saile L; Andresen C; Krämer S; Gu Z; Heilig CE; Kreutzfeldt S; Teleanu V; Fröhling S; Eils R; Schlesner M
Genes Chromosomes Cancer; 2021 May; 60(5):314-331. PubMed ID: 33222322
[TBL] [Abstract][Full Text] [Related]
38. PhySigs: Phylogenetic Inference of Mutational Signature Dynamics.
Christensen S; Leiserson MDM; El-Kebir M
Pac Symp Biocomput; 2020; 25():226-237. PubMed ID: 31797599
[TBL] [Abstract][Full Text] [Related]
39. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
[TBL] [Abstract][Full Text] [Related]
40. Somatic mutational signatures in polyposis and colorectal cancer.
Grolleman JE; Díaz-Gay M; Franch-Expósito S; Castellví-Bel S; de Voer RM
Mol Aspects Med; 2019 Oct; 69():62-72. PubMed ID: 31108140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
